Our Experts

Physician Profile

412-692-5030 Phone
412-692-6076 Fax

Beverly Brozanski, MD

Job Title Clinical Director, Neonatal Intensive Care Unit, Children's Hospital of Pittsburgh of UPMC
Job Title Professor, Department of Pediatrics and Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine
Job Title Assistant Research Faculty, Magee-Womens Research Institute
4401 Penn Avenue
Pittsburgh, PA 15224
412-692-5030 Phone
412-692-6076 Fax

Education and Training

Medical School:

1982 University of Pittsburgh School of Medicine, Pittsburgh, PA

Residency:

1985 Children's Hospital of Pittsburgh of UPMC and University of Pittsburgh School of Medicine, Pittsburgh, PA

Fellowship:

1987 Magee-Womens Hospital and University of Pittsburgh School of Medicine, Pittsburgh, PA 

Memberships

  • American Academy of Pediatrics, Fellow, Sections on Perinatal Medicine and Practice Management
  • Pittsburgh Pediatric Society
  • Midwest Society for Pediatric Research
  • American College of Physician Executives
  • Society for Pediatric Research

Board Certifications

  • National Board of Medical Examiners
  • American Board of Pediatrics
  • American Board of Pediatrics, Sub-Board of Neonatal-Prenatal Medicine

Awards

  • Phi Kappa Phi Honor Society
  • Summa Cum Laude, Duquesne University
  • Ad Hoc Reviewer, Journal of the American Medical Association
  • Beta Gamma Sigma, Business Honor Society
  • NIH Study Section Ad hoc Reviewer Perinatal Studies RFA
  • Ad Hoc Reviewer, Investigative Ophthalmology & Visual Science
  • Ad Hoc Reviewer, Archives of Pediatrics and Adolescent Medicine  
  • Ad Hoc Reviewer, Journal of Perinatology   
  • Society for Pediatric Research
  • Outstanding Neonatologist, Children’s Hospital of Pittsburgh of UPMC
  • “Unsung Clinical Hero” Award, Children’s Hospital of Pittsburgh of UPMC
  • America’s Top Pediatricians, Consumer Research Council of America 
  • Best Doctors in Pittsburgh, Pittsburgh Magazine

Publications

  • Jordan JA, Durso MB, Butchko AR, Jones JG, Brozanski BS.  Evaluating the Near-Term Infant for Early Onset Sepsis:  Progress and Challenges to Consider with 16S rDNA Polymerase Chain Reaction Testing.  J Mol Diag  2006; 8(3):357-63.
  • Brozanski BS, Jones JG, Krohn MJ, Jordan JA.  Use of PCR as a Diagnostic Tool for Neonatal Sepsis Can Result in a Decrease in Use of Antibiotics and Total NICU Length of Stay.  J Perinatol 2006; 26(11):688-692.
  • Jordan JA, Durso MB, Butchko AR, Jones, Brozanski B. Evaluating the Near-Term Infant for Early Onset Sepsis: Progress and Challenges to Consider with 16S rDNA PCR Testing. JMD 2006; 8: 357-36.
  • Owens SM, Brozanski BS, Meyn LA, Wiesenfeld HC. Timing is Everything: Antimicrobial Prophylaxis for Cesarean Section Prior to Skin Incision vs Following Umbilical Cord Clamping. Obstet & Gynecol 2009; 11493):573-9.

    View Dr. Brozanski's full list of publications from PubMed.

Biography Summary

Beverly Brozanski, MD, is a member of the UPMC Newborn Medicine Program at Children's Hospital of Pittsburgh of UPMC. She also is Professor at the University of Pittsburgh School of Medicine in the departments of Pediatrics and Obstetrics, Gynecology and Reproductive Sciences.
 
Dr. Brozanski received her bachelor's degree from Duquesne University, from which she graduated summa cum laude. She received her medical degree from the University of Pittsburgh School of Medicine.
 
Dr. Brozanski completed her pediatric residency at Children's Hospital and the University of Pittsburgh School of Medicine. She completed her fellowship in Neonatal and Perinatal Medicine at Magee-Womens Hospital and the University of Pittsburgh School of Medicine.
 
In addition to her clinical and teaching duties, Dr. Brozanski is interested in neonatal outcomes research and cost effectiveness. Dr. Brozanski represents Children’s Hospital in the Children’s Hospital Neonatology Consortium (CHNC). CHNC has partnered with Child Health Corporation of America to develop tools to evaluate the effectiveness of tertiary neonatal intensive care in their unique patient population. Through the systematic collection and analyses of clinical data on all infants admitted to US children’s hospital neonatal intensive care units, CHNC expects to spearhead benchmarking, quality improvement, and research initiatives that have not previously been possible in their patient population.  As one of the first Quality Improvement projects for CHNC, Dr. Brozanski is working with nine of the 23 CHNC centers to Determine Practice Standards for Central Line Removal in Neonates with Abdominal Wall Defects.

Dr. Brozanski has also served as site-PI for several clinical investigations, including use of inhaled nitric oxide for the prevention of chronic lung disease, the use of rHu-GCSF to reduce the incidence of preeclampsia-associated neutropenia and the use of early treatment with laser for pre-threshold retinopathy of prematurity.


Active Research Projects / Grants

  • Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 days) with Suspected or Complicated Intra-Abdominal Infections
  • Phase 2b Randomized, Double Blind, Placebo Controlled, Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity in Very Low Birth Weight Neonates of BSYX-A110, an Anti-Staphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Infection
  • Trial of Late Surfactant to Prevent BPD:  A Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide
Last Update
February 18, 2010
  • Increase/Decrease Text Size
  • Print This Page
Last Update
February 18, 2010
top